Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Letai

Showing results (11-20 of 182) with videos related to

Pageof 19
Sort By:
Trends in Molecular Medicine|September 10, 2005
BCL-2: found bound and drugged!Anthony Letai
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2018
Targeting B-Cell Lymphoma 2: A Lethal Shortcut in Del(17p) Chronic Lymphocytic LeukemiaAnthony Letai
Blood|October 1, 2011
Targeting Bcl-2 in CLL: cui bono?Anthony Letai
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2015
Cell Death and Cancer Therapy: Don't Forget to Kill the Cancer Cell!Anthony Letai
Cancer Discovery|February 10, 2022
Functional Precision Medicine: Putting Drugs on Patient Cancer Cells and Seeing What HappensAnthony Letai
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2022
Apoptosis: Directly Targeted at LastAnthony Letai
Cancer Cell|August 9, 2022
Precision medicine in AML: Function plus -omics is better than either aloneAnthony Letai
Cancer Research|October 3, 2008
Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737Ozgur Kutuk, Anthony Letai
Breast Cancer Research : BCR|November 1, 2013
Priming BCL-2 to kill: the combination therapy of tamoxifen and ABT-199 in ER+ breast cancerJing Deng, Anthony Letai
The FEBS Journal|November 1, 2021
In Conversation with Tony LetaiEleni Skourti, Anthony Letai
Pageof 19

Showing results (11-20 of 182) with videos related to

Sort By:
Pageof 19
Trends in Molecular Medicine|September 10, 2005
BCL-2: found bound and drugged!Anthony Letai
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2018
Targeting B-Cell Lymphoma 2: A Lethal Shortcut in Del(17p) Chronic Lymphocytic LeukemiaAnthony Letai
Blood|October 1, 2011
Targeting Bcl-2 in CLL: cui bono?Anthony Letai
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2015
Cell Death and Cancer Therapy: Don't Forget to Kill the Cancer Cell!Anthony Letai
Cancer Discovery|February 10, 2022
Functional Precision Medicine: Putting Drugs on Patient Cancer Cells and Seeing What HappensAnthony Letai
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2022
Apoptosis: Directly Targeted at LastAnthony Letai
Cancer Cell|August 9, 2022
Precision medicine in AML: Function plus -omics is better than either aloneAnthony Letai
Cancer Research|October 3, 2008
Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737Ozgur Kutuk, Anthony Letai
Breast Cancer Research : BCR|November 1, 2013
Priming BCL-2 to kill: the combination therapy of tamoxifen and ABT-199 in ER+ breast cancerJing Deng, Anthony Letai
The FEBS Journal|November 1, 2021
In Conversation with Tony LetaiEleni Skourti, Anthony Letai
Pageof 19